MICHELLE STAPP: Open Payments
NPI 1619381902 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,910 in 113 payments from 20 companies in 2025. Trend: 2023 $2,125 · 2024 $2,347 · 2025 $1,910
Food & beverage: $1,910
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $289 |
| ABBVIE INC. | 22 | $232 |
| AstraZeneca Pharmaceuticals LP | 11 | $225 |
| Dexcom, Inc. | 1 | $164 |
| Lilly USA, LLC | 9 | $144 |
| Otsuka America Pharmaceutical, Inc. | 10 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $137 |
| E.R. Squibb & Sons, L.L.C. | 6 | $120 |
| PFIZER INC. | 4 | $77 |
| Viatris Specialty LLC | 4 | $66 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, Dexcom G6 Transmitter, REXULTI, Kerendia, Ozempic, COBENFY.
Industry payments across OK — which companies pay providers there.
